RELA, RELA proto-oncogene, NF-kB subunit, 5970

N. diseases: 483; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4476793
Disease: Abnormal cell morphology
Abnormal cell morphology
0.100 Biomarker phenotype HPO
CUI: C0000833
Disease: Abscess
Abscess
0.010 AlteredExpression phenotype BEFREE Furthermore, IL-8 and TNF-alpha expression and nuclear phosphorylated NF-kappaB p65 expression could be immunohistochemically confirmed in inflamed epithelium with cryptitis or crypt abscess in UC patients. 19369513 2009
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.010 Biomarker group BEFREE The protein expression levels of RAS, RAF, nuclear factor (NF)-κB P65 and P50 as well as inhibitor of NF-κB-α of the TLR4 signaling pathway in AIDS-KS and KS tissues were higher than those in normal tissues. 30651761 2019
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.010 Biomarker disease BEFREE Two miRNAs (hsa-miR-29 and hsa-miR-1) and three TFs (NFIC, NFKB1 and RELA) were critical genes involved in pathological process of ACS. 31550669 2019
CUI: C2118460
Disease: Acute colitis
Acute colitis
0.010 Biomarker disease BEFREE The immunohistochemical expression of two transcription factors hypoxia-inducible factors-1α and nuclear factor-κB p65 has already been described in several disorders, including wound healing, asthma and chronic obstructive lung disease, rheumatoid arthritis, cancer, inflammatory bowel disease, and acute colitis. 29932372 2018
CUI: C0023440
Disease: Acute Erythroblastic Leukemia
Acute Erythroblastic Leukemia
0.020 Biomarker disease BEFREE Administration of the p65 inhibitor parthenolide significantly improved hematology and myelogram indices while prolonging the life span of erythroleukemia mice. 26378023 2015
CUI: C0023440
Disease: Acute Erythroblastic Leukemia
Acute Erythroblastic Leukemia
0.020 Biomarker disease BEFREE Fusion of ZMYND8 and RELA genes in acute erythroid leukemia. 23667654 2013
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.010 AlteredExpression disease BEFREE On the basis of this technique we analyzed p65 gene expression in various types of leukemia: acute myeloblastic leukemia (AML) (n=26); acute lymphoblastic leukemia (ALL) (n=26) and chronic lymphocytic leukemia (CLL) (n=40). 12458326 2002
CUI: C0023465
Disease: Acute monocytic leukemia
Acute monocytic leukemia
0.010 Biomarker disease BEFREE All these findings suggest that NF-κB p65 maybe an attractive candidate for the therapeutic targeting of acute monocytic leukemia. 21901538 2012
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.010 Biomarker disease BEFREE Treatment with dabigatran significantly inhibited the P65 of nuclear factor κB, tumor necrosis factor α, interleukin (IL)‑1β and IL‑6 activities and significantly enhanced the catalase and superoxide dismutase activities in the AMI rabbits. 29115615 2018
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 AlteredExpression disease BEFREE High protein levels of the NF‑κB p65 subunit were observed in the nuclei of cells in the resistin‑treated AP model, compared with the untreated AP model. 27959400 2017
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 AlteredExpression disease BEFREE In the MaR1-treated AP mice, inflammation of the pancreas and the expression of inflammatory cytokines, pancreatic acinar cell apoptosis, Bcl-2 expression, and expression of TLR4, MyD88, and p-NF-kappaB p65 were reduced, but Bax, cleaved caspase-3, and cleaved caspase-9 expression increased. 31671079 2019
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.030 Biomarker disease BEFREE Obesity reduces pancreatic PGC-1α levels and potentiates not only oxidative but also IL-6-mediated inflammatory damage during acute pancreatitis by relieving the binding of PGC-1α to the NF-κB subunit p65. 30570131 2019
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.020 Biomarker disease BEFREE In the present work, we have found that capsaicin suppresses TPA-stimulated activation of NF-kappaB through inhibition of IkappaB alpha degradation and blockade of subsequent nuclear translocation of p65 in human promyelocytic leukemia HL-60 cells. 12214859 2002
CUI: C0023487
Disease: Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia
0.020 Biomarker disease BEFREE TNFα-treated PML<sup>-/-</sup> cells show normal IκBα degradation and NF-κB nuclear translocation but significantly reduced NF-κB DNA binding and phosphorylation of NF-κB p65. 28317833 2017
CUI: C0748355
Disease: Acute respiratory distress
Acute respiratory distress
0.010 AlteredExpression disease BEFREE The protective effect of special electromagnetic field treated water and far infrared rays on endotoxin-induced acute respiratory distress syndrome may result from their role in reducing the levels of IL-1<i>β</i> and IL-6 in serum and the expression level of p65 protein in lung tissue, in addition to reliving inflammatory response, lung coefficient, and lungs edema. 31281400 2019
CUI: C0280141
Disease: Acute Undifferentiated Leukemia
Acute Undifferentiated Leukemia
0.010 Biomarker disease BEFREE The NF-κB subunit RELA occupies promoter regions of crucial MLL target genes and sustains the MLL-dependent leukemia stem cell program. 24054986 2013
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group BEFREE In adenocarcinomas the NF-kappaB p65 expression level was significantly higher in advanced TNM stages (III-IV) than in earlier stages (I-II) (P<.0001), and when NF-kappaB p65 is dichotomized using 50% as the cutoff point (high vs low), a higher NF-kappaB p65 expression level was detected in tumors having either K-RAS (P = .02) or EGFR (P = .009) mutations compared with wildtype tumors. 17078054 2006
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group LHGDN Frequent OPN expression is typical of, but not specific for MM, whereas it appears to select adenocarcinoma cases with p65 and MMP-9 expression, suggesting a link with EGFR signalling pathways. 17493236 2007
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group BEFREE RelA, the p65 subunit of NF-kappa B, was constitutively activated in approximately 67% (16 of 24) of pancreatic adenocarcinomas but not in normal pancreatic tissues. 9918209 1999
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group LHGDN Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. 15256061 2005
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group BEFREE All cases of adenocarcinoma showed strong expression of both RELA and NFκB-1. 26990751 2017
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group BEFREE Paraffin sections of normal epithelial, adenomatous and adenocarcinoma tissues were analysed immunohistochemically for expression of RelA, Bcl-2 and Bcl-x(L) proteins. 15484295 2004
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.060 AlteredExpression group BEFREE Frequent OPN expression is typical of, but not specific for MM, whereas it appears to select adenocarcinoma cases with p65 and MMP-9 expression, suggesting a link with EGFR signalling pathways. 17493236 2007
CUI: C0338106
Disease: Adenocarcinoma of colon
Adenocarcinoma of colon
0.010 AlteredExpression disease BEFREE We found that NFE2L3 expression is regulated by the RELA subunit of NF-κB and that NFE2L3 levels are elevated in patients with colon adenocarcinoma when compared with normal adjacent tissue. 31693889 2019